Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 19/20 | 0.50 |
| ▸ | CCNE1 | P24864 | 11/20 | 0.50 |
| ▸ | CCND1 | P24385 | 7/20 | 0.49 |
| ▸ | CDK6 | Q00534 | 7/20 | 0.49 |
| ▸ | CDK1 | P06493 | 7/20 | 0.47 |
| ▸ | CCNB1 | P14635 | 7/20 | 0.47 |
| ▸ | CCNT1 | O60563 | 5/20 | 0.47 |
| ▸ | CDK4 | P11802 | 5/20 | 0.47 |
| ▸ | CCND3 | P30281 | 5/20 | 0.47 |
| ▸ | CDK7 | P50613 | 5/20 | 0.47 |
| ▸ | CDK9 | P50750 | 5/20 | 0.47 |
| ▸ | CCNH | P51946 | 5/20 | 0.47 |
| ▸ | MNAT1 | P51948 | 5/20 | 0.47 |
| ▸ | CCNA2 | P20248 | 8/20 | 0.46 |
| ▸ | CCNK | O75909 | 1/20 | 0.46 |
| ▸ | CDK12 | Q9NYV4 | 1/20 | 0.46 |
| ▸ | CCNB2 | O95067 | 2/20 | 0.44 |
| ▸ | CCNE2 | O96020 | 2/20 | 0.44 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.44 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26946581 | 0.83 | CDK2 (0.53) | CDK2CCNE1CCND1CDK6CDK1 | |
| SCHEMBL26941920 | 0.83 | CDK2 (0.56) | CDK2CCNE1CCND1CDK6CDK1 | |
| SCHEMBL24477981 | 0.83 | CDK2 (0.53) | CDK2CCNE1CCND1CDK6CDK1 | |
| SCHEMBL29631714 | 0.83 | CDK2 (0.53) | CDK2CCNE1CCND1CDK6CDK1 | |
| SCHEMBL26942400 | 0.82 | CDK2 (0.55) | CDK2CCNE1CCND1CDK6CDK1 | |
| SCHEMBL26942778 | 0.81 | CDK2 (0.53) | CDK2CCNE1CCND1CDK6CDK1 | |
| SCHEMBL30496646 | 0.80 | CDK2 (0.53) | CDK2CCNE1CCND1CDK6CDK1 | |
| SCHEMBL29763101 | 0.80 | CDK2 (0.53) | CDK2CCNE1CCND1CDK6CDK1 | |
| SCHEMBL26918782 | 0.80 | CDK2 (0.53) | CDK2CCNE1CCND1CDK6CDK1 | |
| SCHEMBL26919222 | 0.80 | CDK2 (0.53) | CDK2CCNE1CCND1CDK6CDK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250009745-A1 | CDK INHIBITOR | SHANGHAI QILU PHARMACEUTICAL RESEARCH AND DEVELOPMENT CENTRE LTD. (CN) | 2025-01-09 | — | — | US | disclosed |
| EP-4289835-A1 | CDK INHIBITOR | Shanghai Qilu Pharmaceutical Research and Development Centre Ltd. (CN) | 2023-12-13 | — | — | EP | disclosed |
| EP-4289835-A1 | CDK INHIBITOR | Shanghai Qilu Pharmaceutical Research and Development Centre Ltd. (CN) | 2023-12-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250009745-A1 | CDK INHIBITOR | CDK9, CDKL1, CDK6 | CDK2 11/4885CCNE1 32/4885CCND1 40/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.